Filing Details

Accession Number:
0000921895-23-002084
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-25 17:36:32
Reporting Period:
2023-08-23
Accepted Time:
2023-08-25 17:36:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849146 Lifevantage Corp LFVN Pharmaceutical Preparations (2834) 841097796
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554334 Sudbury Capital Fund, Lp 136 Oak Trail
Coppell TX 75019
No No No Yes
1643192 Judd Dayton 136 Oak Trail
Coppell TX 75019
No No No Yes
1989433 Sudbury Capital Gp, Lp 136 Oak Trail
Coppell TX 75019
No No No Yes
1989435 Sudbury Holdings, Llc 136 Oak Trail
Coppell TX 75019
No No No Yes
1989436 Sudbury Capital Management, Llc 136 Oak Trail
Coppell TX 75019
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-23 3,788 $4.76 736,609 No 4 P Indirect By Sudbury Capital Fund, LP
Common Stock Acquisiton 2023-08-24 7,226 $4.82 743,835 No 4 P Indirect By Sudbury Capital Fund, LP
Common Stock Acquisiton 2023-08-25 5,490 $4.95 749,325 No 4 P Indirect By Sudbury Capital Fund, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sudbury Capital Fund, LP
No 4 P Indirect By Sudbury Capital Fund, LP
No 4 P Indirect By Sudbury Capital Fund, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,416 Direct
Footnotes
  1. This Form 4 is filed jointly by Sudbury Capital Fund, LP ("Sudbury Fund"), Sudbury Capital GP, LP ("Sudbury GP"), Sudbury Holdings, LLC ("Sudbury Holdings"), Sudbury Capital Management, LLC ("Sudbury Management") and Dayton Judd (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  2. Represents securities owned directly by Sudbury Fund. Sudbury GP, as the general partner of Sudbury Fund, may be deemed to beneficially own the securities owned by Sudbury Fund. Sudbury Holdings, as the general partner of Sudbury GP, may be deemed to beneficially own the securities owned by Sudbury Fund. Sudbury Management, as the investment adviser to Sudbury Fund, may be deemed to beneficially own the securities owned by Sudbury Fund. Mr. Judd, as the Sole Member of Sudbury Holdings and Managing Member of Sudbury Management, may be deemed to beneficially own the securities owned by Sudbury Fund.